• Equipped with world-class laboratory equipment and staffed by renowned neurologists and pathologists, the Center for Advanced Neuro Biochemical Diagnostics will offer non-invasive testing for patients as young as 40, enabling early detection and helping reduce Alzheimer’s cases in the UAE and the wider region

Abu Dhabi, United Arab Emirates. April 16, 2025: Setting a new regional benchmark in the fight against Alzheimer’s disease, the National Reference Laboratory (NRL), part of the M42 Group, is establishing the MENA region’s first Center for Advanced Neuro Biochemical Diagnostics dedicated to early detection, in partnership with Neurocode International, global leader of neurology diagnostic solutions. Announced on the sidelines of Abu Dhabi Global Health Week, this Center for Advanced Neuro Biochemical Diagnostics, based in Abu Dhabi, is a pioneering step toward reducing Alzheimer’s cases in the UAE and wider region and transforming neurological diagnostics worldwide.